{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:57:25Z","timestamp":1795021045130,"version":"4.10.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.vaccine.2011.02.013","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T14:17:32Z","timestamp":1298557052000},"page":"2874-2880","source":"Crossref","is-referenced-by-count":21,"title":["Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults"],"prefix":"10.1016","volume":"29","author":[{"given":"Benjamin M.","family":"Stermole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Grandits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie P.","family":"Roediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brychan M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Weintrob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy F.","family":"Crum-Cianflone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas M.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace E.","family":"Macalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Landrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"RR-3","key":"10.1016\/j.vaccine.2011.02.013_bib0005","first-page":"1","article-title":"Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Marin","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2011.02.013_bib0010","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/INF.0b013e3181dbaacf","article-title":"Measles outbreak associated with an international youth sporting event in the United States, 2007","volume":"29","author":"Chen","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"15","key":"10.1016\/j.vaccine.2011.02.013_bib0015","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMoa0706589","article-title":"Recent resurgence of mumps in the United States","volume":"358","author":"Dayan","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.013_bib0020","first-page":"125","article-title":"Brief update: mumps outbreak \u2013 New York and New Jersey, June 2009\u2013January 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2011.02.013_bib0025","first-page":"Q1","article-title":"Recommended adult immunization scheduled \u2013 United States, 2009","volume":"57","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR"},{"issue":"RR-15","key":"10.1016\/j.vaccine.2011.02.013_bib0030","first-page":"1","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Kroger","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2011.02.013_bib0035","doi-asserted-by":"crossref","unstructured":"WHO position on measles vaccines. Vaccine 2009;27(52):7219\u201321.","DOI":"10.1016\/j.vaccine.2009.09.116"},{"issue":"11","key":"10.1016\/j.vaccine.2011.02.013_bib0040","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM198703123161106","article-title":"Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease","volume":"316","author":"Redfield","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.013_bib0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-129-2-199807150-00007","article-title":"Vaccine-associated measles pneumonitis in an adult with AIDS","volume":"129","author":"Angel","year":"1998","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.vaccine.2011.02.013_bib0050","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated Bacille Calmette\u2013Guerin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.013_bib0055","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1542\/peds.108.2.e39","article-title":"Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"issue":"13","key":"10.1016\/j.vaccine.2011.02.013_bib0060","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/0264-410X(94)90247-X","article-title":"Measles seroprevalence and vaccine response in HIV-infected adults","volume":"12","author":"Wallace","year":"1994","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.013_bib0065","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/315246","article-title":"Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults","volume":"181","author":"King","year":"2000","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.013_bib0070","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/520651","article-title":"Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy","volume":"45","author":"Aurpibul","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2011.02.013_bib0075","first-page":"1125","article-title":"Antibody response to measles and rubella vaccine by children with HIV infection","volume":"6","author":"Brena","year":"1993","journal-title":"J Acq Immun Def Synd"},{"issue":"9","key":"10.1016\/j.vaccine.2011.02.013_bib0080","first-page":"1013","article-title":"Response of human immunodeficiency virus-infected adults to measles\u2013rubella vaccination","volume":"6","author":"Sprauer","year":"1993","journal-title":"J Acq Immun Def Synd"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.013_bib0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/505149","article-title":"Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells","volume":"194","author":"Levin","year":"2006","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.013_bib0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1067\/mpd.2001.115972","article-title":"Immunization of HIV-infected children with varicella vaccine","volume":"139","author":"Levin","year":"2001","journal-title":"J Pediatr"},{"issue":"50","key":"10.1016\/j.vaccine.2011.02.013_bib0095","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1016\/j.vaccine.2009.09.063","article-title":"Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART","volume":"27","author":"Belaunzaran-Zamudio","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.02.013_bib0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/IPC.0b013e31815c5e6e","article-title":"Routine vaccination in HIV-infected adults","volume":"16","author":"Landrum","year":"2008","journal-title":"Infect Dis Clin Pract"},{"issue":"6","key":"10.1016\/j.vaccine.2011.02.013_bib0105","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/infdis\/173.6.1320","article-title":"The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune response in infants","volume":"173","author":"Hussey","year":"1996","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.013_bib0110","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/infdis\/168.5.1097","article-title":"Immunologic parameters 2 years after high-titer measles immunization in Peruvian children","volume":"168","author":"Leon","year":"1993","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.013_bib0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00006454-199402000-00006","article-title":"Long term impact of high titer Edmonston-Zagreb measles vaccine on T lymphocyte subsets","volume":"13","author":"Lisse","year":"1994","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2011.02.013_bib0120","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/jama.247.8.1134","article-title":"Assessment of susceptibility to measles and rubella","volume":"247","author":"Preblud","year":"1982","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.013_bib0125","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1542\/peds.2005-2616","article-title":"Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection","volume":"118","author":"Bekker","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.013_bib0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpedi.1994.02170010059012","article-title":"A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection","volume":"148","author":"Frenkel","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.013_bib0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/1096-8652(200102)66:2<92::AID-AJH1023>3.0.CO;2-J","article-title":"Response to measles, mumps, and rubella revaccination among HIV-positive and HIV-negative children and adolescents with hemophilia. Hemophilia growth and development study","volume":"66","author":"Hilgartner","year":"2001","journal-title":"Am J Hematol"},{"issue":"6 Pt 1","key":"10.1016\/j.vaccine.2011.02.013_bib0140","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1542\/peds.111.6.e641","article-title":"Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy","volume":"111","author":"Melvin","year":"2003","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2011.02.013_bib0145","first-page":"523","article-title":"Effects of measles vaccination in HIV infected children","volume":"55","author":"Oldakowska","year":"2001","journal-title":"Przegl Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.013_bib0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/QAI.0b013e31817bec05","article-title":"Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART","volume":"49","author":"Weintrob","year":"2008","journal-title":"J Acq Immun Def Synd"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.013_bib0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0b013e328317cc2d","article-title":"Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study","volume":"23","author":"Crum-Cianflone","year":"2009","journal-title":"Aids"},{"key":"10.1016\/j.vaccine.2011.02.013_bib0160","unstructured":"Diamedix Corporation, a subsidiary of IVAX Diagnostics, Inc. Measles IgG Enzyme Immunoassay Test Kit [package insert], Miami, FL: Diamedix Corporation 2006:1\u20135."},{"key":"10.1016\/j.vaccine.2011.02.013_bib0165","unstructured":"Diamedix Corporation, a subsidiary of IVAX Diagnostics, Inc. Mumps IgG Enzyme Immunoassay Test Kit [package insert], Miami, FL: Diamedix Corporation 2006:1\u20135."},{"key":"10.1016\/j.vaccine.2011.02.013_bib0170","unstructured":"Diamedix Corporation, a subsidiary of IVAX Diagnostics, Inc. Rubella IgG Enzyme Immunoassay Test Kit [package insert], Miami, FL: Diamedix Corporation 2006:1\u2013-8."},{"issue":"6","key":"10.1016\/j.vaccine.2011.02.013_bib0175","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1086\/314491","article-title":"The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults","volume":"178","author":"Sulkowski","year":"1998","journal-title":"J Infect Dis"},{"issue":"Pt 4","key":"10.1016\/j.vaccine.2011.02.013_bib0180","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1099\/vir.0.83601-0","article-title":"Measles virus inhibits human immunodeficiency virus type 1 reverse transcription and replication by blocking cell-cycle progression of CD4+ T lymphocytes","volume":"89","author":"Garcia","year":"2008","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.013_bib0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1086\/430743","article-title":"Inhibition of HIV-1 replication in human lymphoid tissues ex vivo by measles virus","volume":"192","author":"Grivel","year":"2005","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2011.02.013_bib0190","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/340027","article-title":"Suppression of human immunodeficiency virus replication during acute measles","volume":"185","author":"Moss","year":"2002","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.013_bib0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/INF.0b013e318184eed2","article-title":"Suppression of human immunodeficiency virus type 1 viral load during acute measles","volume":"28","author":"Moss","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.013_bib0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/QAI.0b013e31816d9c86","article-title":"suppression among HIV-infected Ugandan children with measles","volume":"48","author":"Ruel","year":"2008","journal-title":"J Acq Immun Def Synd"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.013_bib0205","first-page":"10","article-title":"Concordance of measles and rubella immunity with immunity to mumps, enlisted accessions U.S. Armed Forces, 2000\u20132004","volume":"13","author":"Petruccelli","year":"2007","journal-title":"Med Surveillance Mon Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.013_bib0210","first-page":"540","article-title":"Measles antibody status of HIV-infected prison inmates","volume":"4","author":"Glaser","year":"1991","journal-title":"J Acq Immun Def Synd"},{"issue":"4","key":"10.1016\/j.vaccine.2011.02.013_bib0215","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/515679","article-title":"The prevalence of measles antibody in human immunodeficiency virus-infected patients in northern California","volume":"178","author":"Kemper","year":"1998","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.013_bib0220","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/infdis\/164.5.973","article-title":"Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults","volume":"164","author":"Sha","year":"1991","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.013_bib0225","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/655394","article-title":"Seroprevalence of antibody to mumps virus in the US population, 1999\u20132004","volume":"202","author":"Kutty","year":"2010","journal-title":"J Infect Dis"},{"issue":"50","key":"10.1016\/j.vaccine.2011.02.013_bib0230","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1016\/j.vaccine.2008.08.074","article-title":"Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination","volume":"26","author":"Cohen","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.013_bib0235","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jviromet.2005.08.001","article-title":"Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay","volume":"131","author":"Cohen","year":"2006","journal-title":"J Virol Methods"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.013_bib0240","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titers","volume":"162","author":"Chen","year":"1990","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.02.013_bib0245","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JCM.33.4.811-815.1995","article-title":"Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody","volume":"33","author":"Ratnam","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.02.013_bib0250","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1128\/JCM.43.9.4847-4851.2005","article-title":"Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays","volume":"43","author":"Mauldin","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.02.013_bib0255","series-title":"Centers for disease control and prevention. epidemiology and prevention of vaccine-preventable diseases","year":"2009"},{"issue":"8","key":"10.1016\/j.vaccine.2011.02.013_bib0260","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/424571","article-title":"Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects","volume":"190","author":"Naniche","year":"2004","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11002143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11002143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T21:55:42Z","timestamp":1592344542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11002143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":52,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0264410X11002143"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.02.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}